title: Effect of diuresis versus therapeutic paracentesis on ascitic fluid opsonic activity and serum complement.
abstract: Therapeutic paracentesis has recently been reported to eliminate ascites in patients with cirrhosis more rapidly than diuresis. However, diuresis has been shown to increase ascitic fluid opsonic activity. Patients with adequate ascitic fluid opsonic activity have been reported to be protected from spontaneous bacterial peritonitis. In this randomized controlled trial, 19 patients with cirrhotic ascites were treated with diuresis versus daily therapeutic paracenteses during 20 hospitalizations. Serum and ascitic fluid complement concentrations and ascitic fluid opsonic activity were measured at the beginning and end of treatment. Although opsonic activity increased significantly (p less than 0.01) in patients treated with diuresis, this parameter was stable in the paracentesis group. The stability of the ascitic fluid opsonic activity and complement concentration in the paracentesis group were maintained at the expense of a decrease in serum complement, whereas serum and ascitic fluid complement increased in the diuresis group. Diuresis may have the advantage over therapeutic paracentesis of providing better protection from spontaneous bacterial peritonitis. Study of larger numbers of patients will determine if these changes in complement concentrations and opsonic activity translate into an increased risk of spontaneous bacterial peritonitis in vivo.
authors.affiliation: Liver Unit, University of Southern California School of Medicine, Los Angeles.
authors.forename: B A
authors.initials: BA
authors.lastname: Runyon
authors.forename: M R
authors.initials: MR
authors.lastname: Antillon
authors.forename: A A
authors.initials: AA
authors.lastname: Montano
mesh_terms: D001201:Ascites / Q000628:therapy*; D001202:Ascitic Fluid / Q000032:analysis; D002986:Clinical Trials as Topic; D003165:Complement System Proteins / Q000032:analysis; D004232:Diuretics / Q000627:therapeutic use*; D004322:Drainage / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009895:Opsonin Proteins / Q000032:analysis; D011897:Random Allocation
chemical_list: D004232:Diuretics; D009895:Opsonin Proteins; D003165:Complement System Proteins